Governance

The Board of GARDP determines GARDP’s strategic goals and ensures that management works diligently and efficiently to meet these goals. It receives guidance from the Scientific Advisory Committee, while GARDP staff carry out day-to-day operations, focusing on the core business of developing and delivering treatments for drug-resistant infections.

Board of GARDP

Board of GARDP

The Board of GARDP is comprised of representatives of donor countries and different constituencies, as well as experts in global health, finance and governance from around the world. As the ultimate decision-making body of the organization, the Board establishes GARDP policies and principles, and appoints the Board Chair, Vice-Chair, and Treasurer, as well as  GARDP’s Executive Director. The Board meets at least twice a year.

Ramanan Laxminarayan

Chair

Center for Disease Dynamics, Economics & Policy, USA

John-Arne Røttingen

Vice-Chair

Ministry of Foreign Affairs, Norway

Stanislas
Zuin

Board Treasurer

Independent

Glenda
Gray

Board member

South African Medical Research Council, South Africa

Veronika von Messling

Board member

Federal Ministry of Education and Research, Germany

Hiroki
Nakatani

Board member

Global Research Institute, Keio University, Japan

Bernard
Pécoul

Board member

Drugs for Neglected Diseases initiative, Switzerland

Observers of the Board

Observers of the Board

Observers of the Board include, but are not limited to: a representative from the World Health Organization (a co-founder of GARDP); a representative from DNDi (a co-founder of GARDP); the Chair of the Scientific Advisory Committee; and the Chair of the Donor Partnership Advisory Committee. Observers liaise between the Board and the groups they represent. They offer counsel and participate in all board meetings but do not have voting rights.

Gregg
Alton

Board observer

Independent

Hanan H.
Balkhy

Board observer

World Health Organization

Prabhavathi Fernandes

Board observer

United States

Ambassador Nora Kronig Romero

Board observer

Federal Office of Public Health, Switzerland

The Scientific Advisory Committee

The Scientific Advisory Committee

The Scientific Advisory Committee (SAC) is made up of scientists with expertise in various disciplines within infectious diseases and microbiology. SAC members advise and make recommendations to the Board of GARDP to carry out the organization’s scientific objectives. They also assess GARDP’s R&D strategy and projects, and provide guidance as well as medical and scientific expertise for GARDP’s programmes. SAC Ex-Officio Members represent external organizations at SAC meetings.

Prabhavathi Fernandes

Chair

United States

Karl-Heinz
Altmann

Committee member

Swiss Federal Institute of Technology, Switzerland

Marc
Bonten

Committee member

University Medical Centre Utrecht, The Netherlands

Anthony
Coates

Committee member

St George’s, University of London

Ana Cristina Gales

Committee member

Universidade Federal de São Paulo

Angela Dramowski

Committee member

Tygerberg Hospital/Stellenbosch University, Cape Town

Roy Jamieson

Committee member

OkerPharma Consultancy AB

Mark J Goldberger

Committee member

Fomerly AbbVie, USA

William Hope

Committee member

University of Liverpool, UK

Marc Mendelson

Committee member

University of Cape Town, South Africa

Rudo Mathivha

Committee member

Chris Hani Baragwanath Hospital, South Africa

Malcolm Page

Committee member

Formerly Roche, Switzerland

Andreas Rummelt

Committee member

InterPharmaLink AG

Kamini Walia

Committee member

Indian Council of Medical Research, India

Nicholas White

Ex-officio member

Mahidol University, Thailand

Dr. Valeria Gigante

Ex-officio member

World Health Organization

The Donor Partnership Advisory Committee

The Donor Partnership Advisory Committee

The Donor Partnership Advisory Committee consists of key donors, allowing them to bring their insights to the Board. It helps the Board fulfil its mission by reviewing the success of previous and ongoing donor investments in GARDP’s work, and providing advice on how further funding can deliver the greatest possible impact. It also advises the Board on how GARDP can expand and better manage its partnerships with governments and donors. The Chair of the committee represents the committee at the Board meetings and ensures that key decisions of the Board are brought back to the full committee.

Ambassador Nora Kronig Romero

Chair

Federal Office of Public Health, Switzerland

Jasper
Claessen

Committee member

Ministry of Health, Netherlands

Dr Eiji
Hinoshita

Committee member

Ministry of Health, Labour and Welfare

Louise Norton-Smith

Committee member

Department of Health and Social Care, UK

Dagmar Reitenbach

Committee member

Federal Ministry of Health, Germany

Niresh Bhagwandin

Committee member

South African Medical Research Council, South Africa

The Strategic Partnerships Committee

The Strategic Partnerships Committee

The Strategic Partnerships Committee is a subcommittee of the Board of GARDP. It ensures that GARDP partnerships with the private sector align with GARDP’s vision, mission and objectives.

Glenda
Gray

Chair

South African Medical Research Council, South Africa

Jean-Pierre
Paccaud

Committee member

GARDP

Veronika von Messling

Committee member

Federal Ministry of Education and Research, Germany

Ramanan Laxminarayan

Committee member

Center for Disease Dynamics, Economics & Policy, USA

Dominique Carouge

Committee member

Independent

Rachel Christinat

Committee member

Independent

Gregg Alton

Committee member

Independent

Manica Balasegaram

Committee member

GARDP

Seamus O’Brien

Committee member

GARDP

The Nomination, Remuneration and Safeguarding Committee

The Nomination, Remuneration and Safeguarding Committee

The Nomination, Remuneration and Safeguarding Committee is a subcommittee of the Board of GARDP. Its members are responsible for reviewing key questions about the Board itself (e.g. structure, size, and composition), reviewing organizational changes and decisions that require Board approval, and overseeing safeguarding matters (i.e. formal complaints of abuse of power or harassment).

Ramanan Laxminarayan

Chair

Center for Disease Dynamics, Economics & Policy, USA

Hiroki
Nakatani

Committee member

Global Research Institute, Keio University, Japan

John-Arne Røttingen

Committee member

Ministry of Foreign Affairs, Norway

Stanislas
Zuin

Committee member

Independent

The Audit Committee

The Audit Committee

The Audit Committee is a subcommittee of the Board of GARDP. It is made up of at least two Board members as well as external auditors, and it oversees financial aspects of the organization.

Stanislas Zuin

Chair

Independent

Dominique Carouge

Committee member

Independent

Bernard Pécoul

Committee member

Drugs for Neglected Diseases initiative, Switzerland

Tal Schibler

Committee member

DGE Avocats